| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
35,860,000 |
| Market
Cap: |
2.13(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$20.91 - $62.84 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 9.6 |
| Insider 6 Months : 9.6 |
| Insider 3/6 Months : 19.6 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile RxSight is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. Co.'s proprietary RxSight Light Adjustable Lens system, comprised of RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and accessories, is the first commercially available intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. Co.'s LAL is made of proprietary photosensitive material that changes shape in response to specific patterns of ultraviolet light generated by Co.'s LDD.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
8,000 |
8,000 |
8,000 |
488,000 |
| Total Buy Value |
$406,673 |
$406,673 |
$406,673 |
$6,406,673 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
2 |
2 |
2 |
3 |
| Total Shares Sold |
105,000 |
1,538,333 |
1,624,918 |
1,624,918 |
| Total Sell Value |
$5,844,457 |
$53,213,942 |
$55,783,062 |
$55,783,062 |
| Total People Sold |
3 |
9 |
9 |
9 |
| Total Sell Transactions |
7 |
41 |
48 |
48 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shah Rajeev M. |
10% Owner |
– – • |
2021-08-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,052,796 |
|
-29% |
|
| Weinberg Eric |
Chief Commercial Officer |
• – – |
2021-08-03 |
4 |
B |
$17.03 |
$17 |
I/I |
1 |
301 |
1.91 |
-29% |
|
| Warner Robert Keith |
Director |
– • – |
2021-08-03 |
4 |
B |
$16.00 |
$700,000 |
I/I |
43,750 |
57,128 |
2.1 |
-29% |
|
| Warner Robert Keith |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,378 |
13,378 |
|
- |
|
| Link William J Phd |
Director |
– • • |
2021-08-03 |
4 |
B |
$16.00 |
$500,000 |
D/D |
31,250 |
37,109 |
3.92 |
-29% |
|
| Link William J Phd |
Director |
– • • |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
2,016,778 |
2,016,778 |
|
- |
|
| Schwartz Daniel Mark |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,969 |
407,647 |
|
- |
|
| Weinberg Eric |
Chief Commercial Officer |
• – – |
2021-08-03 |
4 |
B |
$16.00 |
$500,000 |
D/D |
31,250 |
31,250 |
2.74 |
-29% |
|
| Wolfen Richard M. |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,489,805 |
1,762,074 |
|
- |
|
| Wolfen Richard M. |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
76,974 |
78,170 |
|
- |
|
| Tammenoms Bakker Juliet |
Director |
– • – |
2021-08-03 |
4 |
B |
$16.00 |
$10,000,000 |
I/I |
625,000 |
500,000 |
2.1 |
-29% |
|
| Tammenoms Bakker Juliet |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,863,613 |
1,863,613 |
|
- |
|
| Tammenoms Bakker Juliet |
Director |
– • – |
2021-08-03 |
4 |
B |
$16.00 |
$200,000 |
D/D |
12,500 |
18,359 |
2.39 |
-29% |
|
| Robertson Bruce C |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,385,037 |
1,385,037 |
|
- |
|
| Andrews Julie |
Director |
– • – |
2021-08-03 |
4 |
B |
$16.00 |
$250,000 |
D/D |
15,625 |
29,003 |
2.39 |
-29% |
|
| Andrews Julie |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,378 |
13,378 |
|
- |
|
| Corley Jesse Anderson |
Director |
– • – |
2021-08-03 |
4 |
B |
$16.00 |
$1,250,000 |
I/I |
78,125 |
436,201 |
2.1 |
-29% |
|
| Rxsight I, Llc |
10% Owner |
– – • |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,016,778 |
2,016,778 |
|
- |
|
| Kurtz Ronald M Md |
See Remarks |
• • – |
2021-08-03 |
4 |
B |
$16.00 |
$2,000,000 |
D/D |
125,000 |
125,000 |
2.81 |
-29% |
|
| Palmisano Robert J |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,378 |
13,378 |
|
- |
|
| Weinberg Eric |
Chief Commercial Officer |
• – – |
2021-08-02 |
4 |
B |
$17.04 |
$1,533 |
I/I |
90 |
300 |
1.91 |
-29% |
|
| Weinberg Eric |
Chief Commercial Officer |
• – – |
2021-07-30 |
4 |
B |
$16.94 |
$3,557 |
I/I |
210 |
210 |
1.91 |
- |
|
| Corley Jesse Anderson |
Director |
– • – |
2021-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,859 |
5,859 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2021-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,859 |
5,859 |
|
- |
|
| Tammenoms Bakker Juliet |
Director |
– • – |
2021-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,859 |
5,859 |
|
- |
|
150 Records found
|
|
Page 6 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
2.11 (3.44%) 
